Pyrrolopyrazine kinase inhibitors
US7939531B2 · kind B2 · utility
59Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2009 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Feb 20, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.